• 제목/요약/키워드: Macrophage colony-stimulating factor

검색결과 182건 처리시간 0.019초

A Mouse Thymic Stromal Cell Line Producing Macrophage-Colony Stimulating Factor and Interleukin-6

  • Lee, Chong-Kil;Kim, Jeong-Ki;Kim, Kyungjae;Han, Seong-Sun
    • Archives of Pharmacal Research
    • /
    • 제23권3호
    • /
    • pp.252-256
    • /
    • 2000
  • A thymic stromal cell line, TFGD, was established from a thymic tumor mass developed spontaneously in p53 knock out mouse, and was found to produce cytokines that could induce bone marrow hematopoietic stem cells (HSCs) to differentiate into macrophages. The cytokines produced by the TFGD line were assessed by immunoassays. High level of macrophage-colony stimulating factor (M-CSF) and interleukin (IL)-6 was detected in the TFGD-culture supernatant, whereas granulocyte/macrophage-colony stimulating factor (GM-CSF), IL-3, IL-4, IL-5, IL-13, or interferon (IFN)-$\gamma$ was undetectable. Blocking experiments showed that anti-M-CSF monoclonal antibody could neutralize the differentiation-inducing activity shown by the TFGD-culture supernatant. Dot blot analysis of the total RNA isolated from the cultured fetal thymic stromal cells showed that M-CSF transcripts were expressed in the normal thymus. These observations, together with the earlier finding that M-CSF plus IL-6 is the optimal combination of cytokines for the induction of macrophage differentiation from HSCs in vitro, may indicate that thymic macrophages could be generated within the thymus by cytokines involving M-CSF.

  • PDF

Immune Evasion of G-CSF and GM-CSF in Lung Cancer

  • Yeonhee Park;Chaeuk Chung
    • Tuberculosis and Respiratory Diseases
    • /
    • 제87권1호
    • /
    • pp.22-30
    • /
    • 2024
  • Tumor immune evasion is a complex process that involves various mechanisms, such as antigen recognition restriction, immune system suppression, and T cell exhaustion. The tumor microenvironment contains various immune cells involved in immune evasion. Recent studies have demonstrated that granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) induce immune evasion in lung cancer by modulating neutrophils and myeloid-derived suppressor cells. Here we describe the origin and function of G-CSF and GM-CSF, particularly their role in immune evasion in lung cancer. In addition, their effects on programmed death-ligand 1 expression and clinical implications are discussed.

Acute Toxicity Study of Recombinant Granulocyte-Macrophage Colony Stimulating Factor (LBD-005) in ICR mice

  • Kim, Hyoung-Chin;Song, Si-Whan;Cha, Shin-Woo;Shin, Chun-Chul;Ha, Chang-Su;Han, Sang-Seop
    • Biomolecules & Therapeutics
    • /
    • 제1권2호
    • /
    • pp.270-274
    • /
    • 1993
  • The acute toxicity of a recombinant granulocyte-macrophage colony stimulating factor (code name: LBD-005) was evaluated in both sexes of ICR mice, 5~6 weeks old, by the oral, subcutaneous and intravenous routes of administration. Based on the results of the acute toxicity study, LBD-005 was not considered to induce any toxic effect on the mice in mortalities, clinical findings, body weights and gross findings. It is suggested that $LD_50$ values in mice would be >48 mg/kg in the oral route and >24 mg/kg in the subcutaneous or intravenous route.

  • PDF

A STUDY ON ANTIGENICITY OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR(LBD-005) IN MICE AND GUINEA PIGS

  • Park, Jong-Il;Han, Sang-Seop;Roh, Jung-Koo
    • Toxicological Research
    • /
    • 제8권1호
    • /
    • pp.17-27
    • /
    • 1992
  • Antigenicity of Recombinant Granulocyte macrophage colony stimulating factor(LBD-005), a newly developed drug for hematopoietic growth, was investigated in mice and guinea pigs. 1. Mice showed production of antibodies against LBD-005 (100mg/kg) with alumin]m hydroxide gel(alum) as an adjuvant, judged by the heterologous anaphylaxis(PCA) test using rats. On the other hand, antibodies against ovalbumin(OVA) inoculated with alum were definitely detected. 2. In the studies with guinea pigs, both the inoculation of LBD-005 only and of LBD-005 with complete Freund's adjuvant(CFA) as an adjuvant did not produce positive reactions in homologous passive cutaneous anaphylaxis (PCA).

  • PDF

4-WEEK SUBCUTANEOUS TOXICITY STUDY OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (LBD-005) IN RATS

  • Kim, Hyoung-Chin;Boohyon Kang;Han, Sang-Seop;Park, Jung-Koo
    • Toxicological Research
    • /
    • 제8권1호
    • /
    • pp.49-61
    • /
    • 1992
  • Recombinant granulocyte-macrophage colony stimulating factor was subcutaneously administered to both sexes of Sprague-Dawley rats at the doses of 0, 0.5, 1 and 2mg/kg of body weight five days per week for 4 weeks to evaluate the subchronic toxicity. There were decreased 1 and 2 mg/kg. In the serum, changes were decreased alkaline phostatase(ALP) in the female groups dosed at 1 and 2mg/kg, and increased glutamic oxaloacetic transaminiase (GOT)in the male groups dosed at 0.5 and 2.0mg/kg.

  • PDF

ACUTE TOXICITY STUDY OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (LBD-005) IN RATS

  • Kim, Hyoung-Chin;Boohyon Kang;Ha, Chang-Soo;Han, Sang-Seop
    • Toxicological Research
    • /
    • 제8권1호
    • /
    • pp.41-48
    • /
    • 1992
  • The actue toxicity of a recombinant granulocyte macrophage colony-stimulating factor (code name: LBD-005) was evaluated in both sexes of Sprague-Dawley rats, 4 weeks old, by the oral, subcutaneous and intravenous routes of administration. LBD-005 in the acute toxicity study in the rats was not considerde to induce any toxicological effect on the rats in mortalities, clinical findings, body weights and gross findings. It is suggested that $LD_{50}$ values in rats would be >48 mg/kg in the oral route and >12 mg/kg in the subcutaneous or intravenous route.

  • PDF

TERATOGENICITY STUDY OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (LBD-005) IN RABBITS

  • Chung, Moon-Koo;Han, Sang-Seop;Roh, Jung-Koo
    • Toxicological Research
    • /
    • 제9권1호
    • /
    • pp.61-67
    • /
    • 1993
  • LBD-005, a newly developed recombinant granulocyte-macrophage colony-stimulating factor, was at dose levels of 0, 20, 80 and 320ng/kg/day administered subcutaneously to pregnat New Zealand White rabbits during the organogenetic period. The dams were subjected to caesarean section on day 28 of pregnancy. Effects of test substance on dams and embryonal development of fetuses were examined. No treatment-related changes in clinical signs and necropsy findings of dams were observed in all groups. At 80 and 320 ng/kg, a significant decrease in food consumption followed by a loss in body weight was found.

  • PDF

A STUDY ON THE RECOMBINANT GRANULOCYTEMACROPHAGE COLONY STIMULATING FACTOR (LBD-005) FOR PRIMARY SKIN IRRITATION IN RABBITS

  • Park, Jong-Il;Kim, Sung-Hoon;Roh, Jung-Koo
    • Toxicological Research
    • /
    • 제9권1호
    • /
    • pp.69-72
    • /
    • 1993
  • LBD-005, a newly developed recombinant granulocyte-macrophage colony stimulating factor, was tested for primary skin irritation in male New Zealand White rabbits. In the primary skin irritation test, LBD-005 was applied to intact and abraded skins for 24 hours. Primary irritation index was "0" in test and control sites of all animals' thus LBD-005 was evaluated as a non-irritatant on the basis of the criteria of Draize et al. (1994).l. (1994).

  • PDF